A Pilot Study of Stereotactic Radiosurgery Combined With Ipilimumab in Patients With Newly Diagnosed Melanoma Metastases in the Brain and Spine

Trial Profile

A Pilot Study of Stereotactic Radiosurgery Combined With Ipilimumab in Patients With Newly Diagnosed Melanoma Metastases in the Brain and Spine

Discontinued
Phase of Trial: Phase I

Latest Information Update: 17 Nov 2016

At a glance

  • Drugs Ipilimumab (Primary)
  • Indications Brain metastases; Cancer metastases; Malignant melanoma
  • Focus Adverse reactions
  • Most Recent Events

    • 10 Nov 2016 Status changed from suspended to discontinued.
    • 05 Nov 2015 Status changed from recruiting to suspended, as reported by ClinicalTrials.gov
    • 18 Mar 2014 According to the ClinicalTrials.gov record, status changed from active, no longer recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top